Zobrazeno 1 - 10
of 16
pro vyhledávání: '"NOBUYOSHI TAJIRI"'
Autor:
Hideki Iwamoto, Nobuyoshi Tajiri, Ryoko Kuromatsu, Osamu Nakashima, Manabu Satani, Takuji Torimura, Tatsuyuki Tonan, Hajime Aino, Tomotake Shirono, Shigeo Shimose, Koji Okuda, Masahito Nakano, Takashi Niizeki, Shusuke Okamura, Shuji Sumie
Publikováno v:
Digestive and Liver Disease. 48:945-952
Background Poor differentiation and microvascular invasion are indicators of poor outcome after hepatectomy for patients with small hepatocellular carcinoma (HCC). Aims We investigated whether gadoxetic acid-enhanced and diffusion-weighted magnetic r
Autor:
Ryoko Kuromatsu, Kensuke Miyahara, Manabu Satani, Takuji Torimura, Hajime Aino, Nobuyoshi Tajiri, Shuji Sumie, Shusuke Okamura, Shigeo Shimose, Masahito Nakano, Takashi Niizeki
Publikováno v:
Molecular and Clinical Oncology. 5:83-88
Several indices have been proposed to evaluate the systemic inflammatory response (SIR), which has been reported to be a useful prognostic factor in various types of cancer. We investigated the usefulness of the Glasgow Prognostic Score (GPS), neutro
Autor:
Hideki Iwamoto, Manabu Satani, Hironori Koga, Nobuyoshi Tajiri, Shusuke Okamura, Takuji Torimura, Junichi Kurogi, Ryoko Kuromatsu, Masahiko Kajiwara, Shuji Sumie, Satoshi Matsugaki, Shigeo Shimose, Hiroaki Nagamatsu, Masahito Nakano, Takashi Niizeki, Hajime Aino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 77:243-250
Portal vein tumor thrombosis is a critical complication in patients with hepatocellular carcinoma (HCC). This prospective multicenter trial assessed the efficacy of hepatic arterial infusion chemoembolization therapy with cisplatin suspended in lipio
Autor:
Nobuyoshi Tajiri, Takuji Torimura, Shusuke Okamura, Manabu Satani, Masahito Nakano, Masatoshi Tanaka, Takashi Niizeki, Hiroaki Nagamatsu, Hajime Aino, Hironori Koga, Hideki Iwamoto, Shigeo Shimose, Ryoko Kuromatsu, Tomotake Shirono
Publikováno v:
Cancer Medicine
Sorafenib, an oral multikinase inhibitor, is approved for advanced hepatocellular carcinoma (HCC) treatment. However, its therapeutic effect in advanced HCC patients with extrahepatic metastasis remains uncertain. This study aimed to prospectively as
Autor:
Shintaro Abe, Shohei Shimajiri, Michihiko Shibata, Yuichi Honma, Masaru Harada, Miyuki Sato, Akinari Tabaru, Riko Harada, Yuka Katsuki, Ryoichi Narita, Nobuyoshi Tajiri, Masaaki Hiura
Publikováno v:
Hepatology Research. 41:270-276
A 50-year-old woman was referred to our hospital due to liver dysfunction and progressive neurological symptoms. She had previously been diagnosed with nonalcoholic steatohepatitis (NASH). Ursodeoxycholic acid (UDCA) had effectively normalized her se
Autor:
Takuji Torimura, Tsutomu Imaizumi, Jun Akiba, Hironori Koga, Takafumi Yoshida, Masamichi Kojiro, Hisashi Adachi, Junichi Kurogi, Takashi Niizeki, Junji Akiyoshi, Nobuyoshi Tajiri, Kinya Inoue, Michio Sata, Sakae Nagaoka
Publikováno v:
Liver International. 27:1091-1097
Background/Aims: C-reactive protein (CRP) was recently identified as a prognostic factor for patients with hepatocellular carcinoma (HCC) after surgical resection. We investigated the relationship between the serum levels of high sensitivity CRP (H-C
Autor:
Eiji Ando, Hironori Koga, Junichi Kurogi, Takuji Torimura, Ryoko Kuromatsu, Nobuyoshi Tajiri, Mina Kurogi, Hayato Kaida, Masatoshi Ishibashi, Kenkichi Baba, Satoru Matsugaki, Kinya Inoue, Akio Takada, Sakae Nagaoka, Naofumi Hayabuchi, Junji Akiyoshi, Ryukichi Kumashiro, Michio Sata, Masamichi Kojiro, Satoshi Itano
Publikováno v:
Liver International. 26:781-788
Background/Aims: This study aimed to evaluate the usefulness of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (PET) and PET plus computed tomography (CT) fusion images for the detection of extrahepatic metastases of hepatocellular carcino
Autor:
Shusuke Okamura, Manabu Satani, Shingo Yamada, Hiroaki Sumie, Masahito Nakano, Takashi Niizeki, Michio Sata, Shigeo Shimose, Shuji Sumie, Takuji Torimura, Nobuyoshi Tajiri, Ryoko Kuromatsu, Hajime Aino
Publikováno v:
Molecular and Clinical Oncology 2(3):393-398, 2014
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The aim of this study was to evaluate whether there are differences in the clinical characteristics and survival between patients with advanced HCC with extrahepatic met
Autor:
Hiroaki Nagamatsu, Akio Takata, Terufumi Sakai, Norito Matsukuma, Yoichi Yano, Ryoko Kuromatsu, Hironori Koga, Shuji Sumie, Satoru Matsugaki, Masatoshi Tanaka, Masahiko Kajiwara, Junichi Kurogi, Takuji Torimura, Michio Sata, Nobuyoshi Tajiri, Manabu Satani, K Sakata, Hideki Iwamoto, Hajime Aino, Shingo Yamada, Kunitaka Fukuizumi, Noriyuki Ono, Masahito Nakano, Takashi Niizeki
Publikováno v:
Oncology. 84(2)
Background: Sorafenib, an oral multikinase inhibitor, was approved for the treatment of advanced hepatocellular carcinoma (HCC), but has not been adequately evaluated for safety and effectiveness in Japanese patients with advanced HCC. Aims: The purp
Autor:
Yuichi, Honma, Masaru, Harada, Miyuki, Sato, Yuka, Katsuki, Masaaki, Hiura, Michihiko, Shibata, Ryoichi, Narita, Riko, Harada, Shintaro, Abe, Akinari, Tabaru, Nobuyoshi, Tajiri, Shohei, Shimajiri
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 41(3)
A 50-year-old woman was referred to our hospital due to liver dysfunction and progressive neurological symptoms. She had previously been diagnosed with nonalcoholic steatohepatitis (NASH). Ursodeoxycholic acid (UDCA) had effectively normalized her se